Berondo, Tita M.
HRN: 24-24-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CEFUROXIME 500MG (TAB)
12/15/2023
12/22/2023
PO
1 Tab
BID
SP NSVD W Repair
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes